# Cardiovascular risk and lipid-lowering therapy in idiopathic inflammatory myopathies: a call for improved, disease-specific risk assessment

**Authors:** Kimberly Loh, Emily Rose, Sarah Tansley

PMC · DOI: 10.1093/rap/rkaf141 · Rheumatology Advances in Practice · 2025-12-06

## Full-text entities

- **Diseases:** inflammatory myopathies (MESH:D009220)
- **Chemicals:** lipid (MESH:D008055)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12758113/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12758113/full.md

---
Source: https://tomesphere.com/paper/PMC12758113